Sigachi announces advancement of a CF API combination (Vanzacaftor–Tezacaftor–Deutivacaftor) with potential annual revenue of ₹250 crore from Q4 FY2026-27, supported by ongoing collaborations and 2039 patent protection.
AI Assistant
Sigachi Industries Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.